QCM
PCRX icon

Quantinno Capital Management’s Pacira BioSciences PCRX Stock Holding History

Quantinno Capital Management’s Portfolio PCRX Stock Details PCRX Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$569K Buy
22,426
+1,973
+10% +$46.6K ﹤0.01% 2913
2026
Q1 		$462K Buy
20,453
+6,410
+46% +$142K ﹤0.01% 2771
2025
Q4 		$363K Buy
14,043
+4,758
+51% +$113K ﹤0.01% 2702
2025
Q3 		$239K Sell
9,285
-3,672
-28% -$90.2K ﹤0.01% 2632
2025
Q2 		$310K Buy
+12,957
New +$327K ﹤0.01% 1991

Other funds holding PCRX

BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
DPCM
Doma Perpetual Capital Management Miami, Florida $431M AUM 13.21% 1-Year Est. Return
Vanguard Portfolio Management
Vanguard Portfolio Management Malvern, Pennsylvania $2.22T AUM
Dimensional Fund Advisors
Dimensional Fund Advisors Austin, Texas $552B AUM 44.19% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
D.E. Shaw & Co
D.E. Shaw & Co New York $210B AUM 57.28% 1-Year Est. Return
Renaissance Technologies
Renaissance Technologies New York $72.6B AUM 54.88% 1-Year Est. Return
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM
Goldman Sachs
Goldman Sachs New York $1.15T AUM 47.82% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return

Quantinno Capital Management's PCRX Position: Q2 2026 in Review

Quantinno Capital Management increased its Pacira BioSciences (PCRX) stake by 9.6% in Q2 2026, buying an estimated $46.6K and bringing the position to 22,426 shares worth $569K. The position accounts for ﹤0.01% of the portfolio, ranked #2913.

Quantinno Capital Management first reported a position in PCRX in Q2 2025 and has held it in 5 quarters since. 253 funds tracked by Wall St. Rank hold PCRX as of Q2 2026.

  • Quantinno Capital Management held 22,426 shares of Pacira BioSciences worth $569K as of Q2 2026.
  • Quantinno Capital Management bought 1,973 Pacira BioSciences shares in Q2 2026, an estimated $46.6K.
  • Pacira BioSciences made up ﹤0.01% of Quantinno Capital Management's portfolio in Q2 2026, its #2913 holding.
  • Quantinno Capital Management first reported a position in Pacira BioSciences in Q2 2025 and has held it in 5 quarters since.
  • 253 funds tracked by Wall St. Rank held Pacira BioSciences as of Q2 2026.

Based on Quantinno Capital Management's 13F filing for Q2 2026, filed 13 Aug 2026.